Hypoxia markers in human osteosarcoma: an exploratory study. Academic Article uri icon

Overview

abstract

  • Neoplastic cells growing under hypoxic conditions exhibit a more aggressive phenotype by activating a cascade of molecular events partly mediated by hypoxia-inducible transcription factor (HIF-1alpha) and vascular endothelial growth factor (VEGF). The roles of these markers have been studied previously in several cancer lines. We ascertained the frequency of HIF-1alpha expression, VEGF expression, the degree of neovascularization, and cell proliferation in osteosarcoma samples. Samples from osteosarcoma patients were assessed for HIF-1alpha and VEGF protein expression using immunohistochemistry, neovascularization using antibodies for Factor VIII, and cell proliferation using the Ki-67 labeling index. Associations between these parameters and clinical features were examined. HIF-1alpha staining was positive in 35% of patients and metastases were present in 61% of these HIF-1alpha-positive patients. VEGF protein expression was detected in 69% of patients, 92% of whom were female. We observed an insignificant trend for a higher frequency of VEGF expression in the high-grade as compared to low-grade osteosarcoma. We observed no association between vascular density and proliferation index and any clinical parameters. We found an association between HIF-1alpha expression and metastatic disease and between VEGF expression and female gender.

publication date

  • June 5, 2008

Research

keywords

  • Biomarkers, Tumor
  • Bone Neoplasms
  • Gene Expression Regulation, Neoplastic
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Osteosarcoma
  • Vascular Endothelial Growth Factor A

Identity

PubMed Central ID

  • PMC2493019

Scopus Document Identifier

  • 50649118599

Digital Object Identifier (DOI)

  • 10.1053/hupa.2000.8441

PubMed ID

  • 18528739

Additional Document Info

volume

  • 466

issue

  • 9